Identification of head and neck squamous cell carcinoma biomarker candidates through proteomic analysis of cancer cell secretome.
暂无分享,去创建一个
Akhilesh Pandey | Aditi Chatterjee | Arivusudar Marimuthu | David Sidransky | Gajanan Sathe | Nandini A. Sahasrabuddhe | Aneesha Radhakrishnan | Sandip Chavan | Santosh Renuse | A. Pandey | S. Renuse | A. Radhakrishnan | Arivusudar Marimuthu | G. Sathe | S. Chavan | Sartaj Ahmad | A. Chatterjee | H. Harsha | J. Califano | D. Sidransky | M. Barbhuiya | R. Kumar | Joseph Califano | S. Srikanth | Rekha V Kumar | H C Harsha | Nandini A Sahasrabuddhe | Srinivas M Srikanth | Sartaj Ahmad | Mustafa A Barbhuiya | A. Pandey | A. Pandey | Aditi Chatterjee
[1] A. Lewiński,et al. Expression of Insulin‐like Growth Factor I (IGF‐I) Gene and of Genes for IGF‐Binding Proteins 1, 2, 3, 4 (IGFBP‐1—IGFBP‐4) in Non‐neoplastic Human Thyroid Cells and in Certain Human Thyroid Cancers. Effect of Exogenous IGF‐I on This Expression , 2004, Endocrine research.
[2] A. Hui,et al. Potentially Novel Candidate Biomarkers for Head and Neck Squamous Cell Carcinoma Identified Using an Integrated Cell Line-based Discovery Strategy* , 2012, Molecular & Cellular Proteomics.
[3] Kumaran Kandasamy,et al. Human Proteinpedia: a unified discovery resource for proteomics research , 2008, Nucleic Acids Res..
[4] D. Tai,et al. Candidate Serological Biomarkers for Cancer Identified from the Secretomes of 23 Cancer Cell Lines and the Human Protein Atlas* , 2010, Molecular & Cellular Proteomics.
[5] V. Hwa,et al. The Insulin-like Growth Factor-binding Protein (igfbp) Superfamily* , 2022 .
[6] M. Mann,et al. Parts per Million Mass Accuracy on an Orbitrap Mass Spectrometer via Lock Mass Injection into a C-trap*S , 2005, Molecular & Cellular Proteomics.
[7] E. Diamandis,et al. Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer. , 2009, Journal of proteome research.
[8] K. Kurachi,et al. Isolation and characterization of cDNAs encoding the heavy chain of human inter-alpha-trypsin inhibitor (I alpha TI): unambiguous evidence for multipolypeptide chain structure of I alpha TI. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[9] R. Knuechel,et al. Tumor-associated fibroblasts (part I): Active stromal participants in tumor development and progression? , 2002, Histology and histopathology.
[10] C. Masters,et al. Recombinant human amyloid precursor‐like protein 2 (APLP2) expressed in the yeast Pichia pastoris can stimulate neurite outgrowth , 1999, FEBS letters.
[11] Hideji Nakamura,et al. Hepatoma-derived Growth Factor Stimulates Cell Growth after Translocation to the Nucleus by Nuclear Localization Signals* , 2002, The Journal of Biological Chemistry.
[12] A. Vlahou,et al. Secretome proteomics for discovery of cancer biomarkers. , 2010, Journal of proteomics.
[13] R. Lewensohn,et al. Expression of Ku86 confers favorable outcome of tonsillar carcinoma treated with radiotherapy , 2003, Head & neck.
[14] N. Tsuji,et al. Olfactomedin 4 promotes S‐phase transition in proliferation of pancreatic cancer cells , 2007, Cancer science.
[15] E. Diamandis,et al. Human Kallikrein 6 Expression in Salivary Gland Tumors , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[16] N. Kitamura,et al. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma. , 2000, Cancer research.
[17] F. Cuzin,et al. APLP2, a member of the Alzheimer precursor protein family, is required for correct genomic segregation in dividing mouse cells , 1998, The EMBO journal.
[18] Farin Kamangar,et al. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] A. Forastiere,et al. Head and neck cancer: changing epidemiology, diagnosis, and treatment. , 2008, Mayo Clinic proceedings.
[20] W. Jiang,et al. Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells. , 2001, International journal of oncology.
[21] M. Spaargaren,et al. Multiple myeloma cells catalyze hepatocyte growth factor (HGF) activation by secreting the serine protease HGF-activator. , 2004, Blood.
[22] T. Mcclanahan,et al. Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.
[23] S. Brunak,et al. SignalP 4.0: discriminating signal peptides from transmembrane regions , 2011, Nature Methods.
[24] M. Kawaguchi,et al. Hepatocyte growth factor activator is a serum activator of single‐chain precursor macrophage‐stimulating protein , 2009, The FEBS journal.
[25] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.
[26] C. Chi,et al. Increased expression of amyloid precursor protein in oral squamous cell carcinoma , 2004, International journal of cancer.
[27] Ho-Yyoung Lee,et al. Insulin‐like growth factor binding protein‐3 suppresses vascular endothelial growth factor expression and tumor angiogenesis in head and neck squamous cell carcinoma , 2012, Cancer science.
[28] A. Maitra,et al. Increased expression and processing of the Alzheimer amyloid precursor protein in pancreatic cancer may influence cellular proliferation. , 2003, Cancer research.
[29] R. Timpl,et al. A Comparative Analysis of the Fibulin Protein Family , 2007, Journal of Biological Chemistry.
[30] Arndt Hartmann,et al. Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: A systematic expression analysis , 2008, BMC Cancer.
[31] Toshikazu Nakamura,et al. Hepatocyte growth factor and the Met system as a mediator of tumor–stromal interactions , 2006, International journal of cancer.
[32] M.-H. Wang,et al. Macrophage‐Stimulating Protein and RON Receptor Tyrosine Kinase: Potential Regulators of Macrophage Inflammatory Activities , 2002, Scandinavian journal of immunology.
[33] T. Bayer,et al. Histone Deacetylase Inhibitor Valproic Acid Inhibits Cancer Cell Proliferation via Down-regulation of the Alzheimer Amyloid Precursor Protein* , 2010, The Journal of Biological Chemistry.
[34] Ying Liang,et al. Identification of guanylate-binding protein 1 as a potential oral cancer marker involved in cell invasion using omics-based analysis. , 2011, Journal of proteome research.
[35] Hanno Steen,et al. Development of human protein reference database as an initial platform for approaching systems biology in humans. , 2003, Genome research.
[36] N. Blom,et al. Feature-based prediction of non-classical and leaderless protein secretion. , 2004, Protein engineering, design & selection : PEDS.
[37] H. Tsubouchi,et al. Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c‐met genes in human glioma cells in vitro , 1995, FEBS letters.
[38] W. Fang,et al. Increased expression of hepatoma‐derived growth factor correlates with poor prognosis in human nasopharyngeal carcinoma , 2011, Histopathology.
[39] Kumaran Kandasamy,et al. SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome , 2010, Cancer biology & therapy.
[40] S. Mathivanan,et al. Exosomes: extracellular organelles important in intercellular communication. , 2010, Journal of proteomics.
[41] X. Chen,et al. Expression of Caveolin-1 in tongue squamous cell carcinoma by quantum dots , 2010, European journal of histochemistry : EJH.
[42] Y. L. Ramachandra,et al. Human Proteinpedia enables sharing of human protein data , 2008, Nature Biotechnology.
[43] E. Diamandis,et al. Proteomics Analysis of Conditioned Media from Three Breast Cancer Cell Lines , 2007, Molecular & Cellular Proteomics.
[44] J. Shah,et al. Treatment of cancer of the head and neck , 1995, CA: a cancer journal for clinicians.
[45] S. Sisodia,et al. A role for amyloid precursor-like protein 2 in corneal epithelial wound healing. , 1998, Investigative ophthalmology & visual science.
[46] C. Stephan,et al. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers. , 2008, Journal of proteome research.
[47] Nandini A. Sahasrabuddhe,et al. Quantitative tissue proteomics of esophageal squamous cell carcinoma for novel biomarker discovery , 2011, Cancer biology & therapy.
[48] S. Fedele,et al. The World Cancer Report and the burden of oral cancer. , 2004, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[49] N. Katunuma,et al. Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. , 2005, The journal of medical investigation : JMI.
[50] H. Aburatani,et al. Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth. , 2009, Cancer research.
[51] A. Garden,et al. DNA Repair Biomarker Profiling of Head and Neck Cancer: Ku80 Expression Predicts Locoregional Failure and Death following Radiotherapy , 2011, Clinical Cancer Research.
[52] Wenli Liu,et al. The glycoprotein hGC-1 binds to cadherin and lectins. , 2006, Experimental cell research.
[53] R. Kursawe,et al. Evidence for a role of the amyloid precursor protein in thyroid carcinogenesis. , 2008, The Journal of endocrinology.
[54] Eithne Costello,et al. A technically detailed and pragmatic protocol for quantitative serum proteomics using iTRAQ. , 2009, Journal of proteomics.
[55] S. Mukai,et al. Activation of hepatocyte growth factor activator zymogen (pro‐HGFA) by human kallikrein 1‐related peptidases , 2008, The FEBS journal.
[56] E. Diamandis,et al. Identification of Five Candidate Lung Cancer Biomarkers by Proteomics Analysis of Conditioned Media of Four Lung Cancer Cell Lines* , 2009, Molecular & Cellular Proteomics.
[57] Li‐yu Lee,et al. Identification of candidate nasopharyngeal carcinoma serum biomarkers by cancer cell secretome and tissue transcriptome analysis: Potential usage of cystatin A for predicting nodal stage and poor prognosis , 2010, Proteomics.
[58] Kai-Ping Chang,et al. Cell secretome analysis using hollow fiber culture system leads to the discovery of CLIC1 protein as a novel plasma marker for nasopharyngeal carcinoma. , 2009, Journal of Proteome Research.
[59] Jens M. Rick,et al. Quantitative mass spectrometry in proteomics: a critical review , 2007, Analytical and bioanalytical chemistry.
[60] N. Nakaya,et al. Olfactomedin Domain-Containing Proteins: Possible Mechanisms of Action and Functions in Normal Development and Pathology , 2009, Molecular Neurobiology.
[61] N. Tsuji,et al. Specific overexpression of OLFM4GW112/hGC−1 mRNA in colon, breast and lung cancer tissues detected using quantitative analysis , 2007, Cancer science.
[62] R. Ralhan,et al. Identification of proteins secreted by head and neck cancer cell lines using LC‐MS/MS: Strategy for discovery of candidate serological biomarkers , 2011, Proteomics.
[63] G. Rodgers,et al. Expression of hGC‐1 is correlated with differentiation of gastric carcinoma , 2007, Histopathology.
[64] E. Masliah,et al. Distribution of an APP homolog, APLP2, in the mouse olfactory system: a potential role for APLP2 in axogenesis , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[65] Nandini A. Sahasrabuddhe,et al. SILAC‐based quantitative proteomic analysis of gastric cancer secretome , 2013, Proteomics. Clinical applications.
[66] H. Rochefort,et al. Estradiol and fibulin‐1 inhibit motility of human ovarian‐ and breast‐cancer cells induced by fibronectin , 1998, International journal of cancer.
[67] Chuan-Yuan Li,et al. GW112, A Novel Antiapoptotic Protein That Promotes Tumor Growth , 2004, Cancer Research.
[68] J. Thacker,et al. The mammalian XRCC genes: their roles in DNA repair and genetic stability. , 2003, DNA repair.